Annual Cash & Cash Equivalents
$241.58 M
-$607.05 M-71.53%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual cash & cash equivalents is $241.58 million, with the most recent change of -$607.05 million (-71.53%) on December 31, 2023.
- During the last 3 years, VIR annual cash & cash equivalents has fallen by -$195.00 million (-44.67%).
- VIR annual cash & cash equivalents is now -71.53% below its all-time high of $848.63 million, reached on December 31, 2022.
Performance
VIR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$168.35 M
-$128.51 M-43.29%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly cash and cash equivalents is $168.35 million, with the most recent change of -$128.51 million (-43.29%) on September 30, 2024.
- Over the past year, VIR quarterly cash and cash equivalents has dropped by -$128.51 million (-43.29%).
- VIR quarterly cash and cash equivalents is now -88.82% below its all-time high of $1.51 billion, reached on June 30, 2022.
Performance
VIR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VIR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.5% | -43.3% |
| 3 y3 years | -44.7% | -79.6% |
| 5 y5 years | +407.5% | -79.6% |
VIR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.5% | at low | -88.8% | +4.8% |
| 5 y | 5-year | -71.5% | +121.0% | -88.8% | +54.0% |
| alltime | all time | -71.5% | +407.5% | -88.8% | +253.7% |
Vir Biotechnology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $168.35 M(-43.3%) |
| Jun 2024 | - | $296.86 M(+84.7%) |
| Mar 2024 | - | $160.71 M(-33.5%) |
| Dec 2023 | $241.58 M(-71.5%) | $241.58 M(-46.6%) |
| Sep 2023 | - | $452.10 M(-32.2%) |
| Jun 2023 | - | $666.95 M(-19.1%) |
| Mar 2023 | - | $824.91 M(-2.8%) |
| Dec 2022 | $848.63 M(+144.0%) | $848.63 M(-11.9%) |
| Sep 2022 | - | $963.74 M(-36.0%) |
| Jun 2022 | - | $1.51 B(+85.3%) |
| Mar 2022 | - | $812.36 M(+133.6%) |
| Dec 2021 | $347.81 M | $347.81 M(-51.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $714.52 M(-3.7%) |
| Jun 2021 | - | $741.95 M(+42.3%) |
| Mar 2021 | - | $521.40 M(+19.4%) |
| Dec 2020 | $436.57 M(+299.3%) | $436.57 M(-5.6%) |
| Sep 2020 | - | $462.52 M(+24.4%) |
| Jun 2020 | - | $371.78 M(+120.7%) |
| Mar 2020 | - | $168.42 M(+54.0%) |
| Dec 2019 | $109.33 M(+129.7%) | $109.33 M(+16.7%) |
| Sep 2019 | - | $93.70 M(+16.1%) |
| Jun 2019 | - | $80.68 M(+69.5%) |
| Dec 2018 | $47.60 M(-74.7%) | $47.60 M |
| Dec 2017 | $187.92 M | - |
FAQ
- What is Vir Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vir Biotechnology?
- What is Vir Biotechnology annual cash & cash equivalents year-on-year change?
- What is Vir Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vir Biotechnology?
- What is Vir Biotechnology quarterly cash and cash equivalents year-on-year change?
What is Vir Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of VIR is $241.58 M
What is the all time high annual cash & cash equivalents for Vir Biotechnology?
Vir Biotechnology all-time high annual cash & cash equivalents is $848.63 M
What is Vir Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, VIR annual cash & cash equivalents has changed by -$607.05 M (-71.53%)
What is Vir Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VIR is $168.35 M
What is the all time high quarterly cash and cash equivalents for Vir Biotechnology?
Vir Biotechnology all-time high quarterly cash and cash equivalents is $1.51 B
What is Vir Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, VIR quarterly cash and cash equivalents has changed by -$128.51 M (-43.29%)